Using CT imaging to find radiomic signatures in surgically resected NSCLC

Giulia Mazzaschi - University Hospital Parma, Parma, Italy
Using CT imaging to find radiomic signatures in surgically resected NSCLC ( Giulia Mazzaschi - University Hospital Parma, Parma, Italy )
18 Apr 2019

The role of afatinib in patients with EGFR NSCLC

Dr Antonio Passaro - European Institute of Oncology, Milan, Italy
The role of afatinib in patients with EGFR  NSCLC ( Dr Antonio Passaro - European Institute of Oncology, Milan, Italy )
18 Apr 2019

Efficacy and immune correlates of the SRA737 plus LDG regimen in combination with anti-PD-L1 in an SCLC model

Dr Triparna Sen - MD Anderson Cancer Center, Houston, Texas
Efficacy and immune correlates of the SRA737 plus LDG regimen in combination with anti-PD-L1 in an SCLC model ( Dr Triparna Sen - MD Anderson Cancer Center, Houston, Texas )
15 Apr 2019

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI

Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI ( Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA )
15 Apr 2019

Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease

Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA
Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )
15 Apr 2019

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases

Dr Marina Garassino - National Tumor Institute, Milan, Italy
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases ( Dr Marina Garassino - National Tumor Institute, Milan, Italy )
15 Apr 2019

MYSTIC: Developing biomarkers for metastatic NSCLC

Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
MYSTIC: Developing biomarkers for metastatic NSCLC ( Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )
11 Apr 2019

TATTON: Updated results for patients with EGFR-mutant NSCLC

Prof Leica Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Updated results for patients with EGFR-mutant NSCLC ( Prof Leica Sequist - Massachusetts General Hospital, Boston, USA )
11 Apr 2019

KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer

Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
11 Apr 2019

Perception of tobacco use in young adults of urban India

Ms Soumita Ghose - Tata Medical Centre, Kolkata, India
Perception of tobacco use in young adults of urban India ( Ms Soumita Ghose - Tata Medical Centre, Kolkata, India )
28 Mar 2019

Nivolumab in combination with CIMAvax-EGF for lung cancer

Dr Grace Dy - Roswell Park Cancer Institute, USA
Nivolumab in combination with CIMAvax-EGF for lung cancer ( Dr Grace Dy - Roswell Park Cancer Institute, USA )
4 Jan 2019

Alcohol consumption and cognitive dissonance in the west

Prof Terry Slevin, Public Health Association of Australia
Alcohol consumption and cognitive dissonance in the west ( Prof Terry Slevin, Public Health Association of Australia )
6 Nov 2018